Jillian Clare Kohler

Biography

Jillian Clare Kohler is a Professor at the Leslie Dan Faculty of Pharmacy, the Dalla Lana School of Public Health and the Munk School of Global Affairs and Public Policy.

Her research focuses on global access to essential medicines. More specifically, she focuses her research on issues that are linked to anti-corruption, transparency and accountability in the pharmaceutical sector, as well as those related to trade issues and intellectual property rights.

She is also the Director of the WHO Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector.

Awards and Accomplishments

• Connaught Global Challenge Award 2020
• Canadian Women in Global Health 2018
• Inaugural founder and Director of the WHO Collaborating Centre for Governance, Transparency and Accountability in the Pharmaceutical Sector
• Technical advisor to the Access to Medicines Index and the former WHO Good Governance for Medicines Programme
• Peter and Patricia Gruber Fellowship in Global Justice at Yale University in 2013

Select Publications

• Jillian Clare Kohler, Andrea Bowra. Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Globalization and Health (2020) 16:101.  https://doi.org/10.1186/s12992-020-00629-5
• Wong, A.S., Kohler, J.C. Social capital and public health: responding to the COVID-19 pandemic. Global Health 16, 88 (2020). https://doi.org/10.1186/s12992-020-00615-x
• Jillian Clare Kohler and Wright, T. The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of  the COVID-19 Pandemic. J of Pharm Policy and Pract 13, 58 (2020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485191/
• Hafner, T., Banda, M., Kohler, J. et al. Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’. J of Pharm Policy and Pract 13, 38 (2020). https://doi.org/10.1186/s40545-020-00242-2
• Kohler, J.C., Mackey, T.K. Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines. BMC Med 18, 193 (2020). https://doi.org/10.1186/s12916-020-01661-3
• Jillian Clare Kohler & Deirdre Dimancesco (2020) The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk, Global Health Action, 13:sup1, DOI: 10.1080/16549716.2019.1694745
• McLean M, Kohler JC, Edwards D. Assessing national governance of medicine promotion: an exploratory study in Ghana to trial a structured set of indicators. J Pharm Policy Pract. 2019;12:26. Published 2019 Sep 4doi:10.1186/s40545-019-0187-9
• Jillian Clare Kohler. “I Know It When I See It: The Challenges of Addressing Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems””. International Journal of Health Policy and Management. (2019), 8(9), 563–566   http://www.ijhpm.com/article_3643_b990f405cca89ba767be6d067a03b7d2.pdf
• Jillian Clare Kohler, Tomas Chang Pico, Taryn Vian, Tim K. Mackey. “The Global Wicked Problem of Corruption and Its Risks for Access to HIV/AIDS Medicines”. Clinical Pharmacology & Therapeutics 104(6) August 2018.  https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.1172
• Anne Paschke, Deirdre Dimancesco, Taryn Vian, Jillian C Kohler & Gilles Forte. “Increasing transparency and accountability in national pharmaceutical systems”. Bulletin of the World Health Organization. 2018;96(11):782 791  http://dx.doi.org/10.2471/BLT.17.206516https://www.who.int/bulletin/volumes/96/11/en/
• Tim K Mackey, Taryn Vian & Jillian Kohler. “The sustainable development goals as a framework to combat health-sector corruption”. Bulletin of the World Health Organization 2018;96:634–643. http://dx.doi.org/10.2471/BLT.18.209502
• Mackey TK, Kohler JC, Lewis M, Vian T. “Combating corruption in global health”. Science Translational Medicine. Aug 9, 2017 http://stm.sciencemag.org/content/9/402/eaaf9547
• Thorsteinsdóttir H, Ovtcharenko N,  Kohler JC. “Corporate social responsibility to improve access to medicines: the case of Brazil”. Globalization and Health 2017 13:10; DOI: 10.1186/s12992-017-02357 https://globalizationandhealth.biomedcentral.com/articles/10.1186/s12992-017-0235-7
• Kohler JC, Mackey TK, Ovtcharenko N. “Why the MDGs need good governance in pharmaceutical systems to promote global health”. Kohler et al. BMC Public Health. 2014, 14:63http://www.biomedcentral.com/content/pdf/1471-2458-14-63.pdf